Business Description
Transgenic Group Inc
ISIN : JP3635720000
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.1 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | 24.92 | |||||
Interest Coverage | 1.88 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.78 | |||||
Beneish M-Score | -1.98 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7 | |||||
3-Year EBITDA Growth Rate | -36.5 | |||||
3-Year EPS without NRI Growth Rate | -64.8 | |||||
3-Year Book Growth Rate | 7.9 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.99 | |||||
9-Day RSI | 47.53 | |||||
14-Day RSI | 46.33 | |||||
6-1 Month Momentum % | 0.84 | |||||
12-1 Month Momentum % | -13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.69 | |||||
Quick Ratio | 1.78 | |||||
Cash Ratio | 1.02 | |||||
Days Inventory | 81.96 | |||||
Days Sales Outstanding | 34.4 | |||||
Days Payable | 15.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.29 | |||||
Dividend Payout Ratio | 1.47 | |||||
Forward Dividend Yield % | 2.59 | |||||
5-Year Yield-on-Cost % | 1.29 | |||||
3-Year Average Share Buyback Ratio | 1.5 | |||||
Shareholder Yield % | -5.78 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 17.19 | |||||
Operating Margin % | 0.68 | |||||
Net Margin % | 0.03 | |||||
FCF Margin % | -5.03 | |||||
ROE % | 0.07 | |||||
ROA % | 0.04 | |||||
ROIC % | 0.13 | |||||
3-Year ROIIC % | -36.53 | |||||
ROC (Joel Greenblatt) % | 2.01 | |||||
ROCE % | 1.19 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 1288.89 | |||||
PE Ratio without NRI | 113.95 | |||||
Shiller PE Ratio | 19.51 | |||||
PS Ratio | 0.3 | |||||
PB Ratio | 0.65 | |||||
Price-to-Tangible-Book | 0.72 | |||||
EV-to-EBIT | 40.07 | |||||
EV-to-EBITDA | 40.07 | |||||
EV-to-Revenue | 0.28 | |||||
EV-to-FCF | -5.59 | |||||
Price-to-Projected-FCF | 0.98 | |||||
Price-to-Median-PS-Value | 0.32 | |||||
Price-to-Graham-Number | 1.91 | |||||
Price-to-Net-Current-Asset-Value | 1.46 | |||||
Earnings Yield (Greenblatt) % | 2.49 | |||||
FCF Yield % | -17.09 | |||||
Forward Rate of Return (Yacktman) % | 28.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Transgenic Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 13,083.458 | ||
EPS (TTM) (円) | 0.18 | ||
Beta | 0.55 | ||
Volatility % | 21.26 | ||
14-Day RSI | 46.33 | ||
14-Day ATR (円) | 4.665493 | ||
20-Day SMA (円) | 232.15 | ||
12-1 Month Momentum % | -13 | ||
52-Week Range (円) | 220 - 294 | ||
Shares Outstanding (Mil) | 16.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Transgenic Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Transgenic Group Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Transgenic Group Inc Frequently Asked Questions
What is Transgenic Group Inc(TSE:2342)'s stock price today?
When is next earnings date of Transgenic Group Inc(TSE:2342)?
Does Transgenic Group Inc(TSE:2342) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |